Non-femoral focused transaxillary access in TAVI: GARY data analysis and future trends

Background In patients not suitable for transfemoral transcatheter aortic valve implantation (TAVI), several access strategies can be chosen. Aim To evaluate the use and patient outcomes of transaxillary (TAx), transapical (TA), and transaortic (TAo) as alternative access for TAVI in Germany; to fur...

Full description

Saved in:
Bibliographic Details
Published inClinical research in cardiology Vol. 114; no. 3; pp. 323 - 331
Main Authors Meertens, Max M., Adam, Matti, Beckmann, Andreas, Ensminger, Stephan, Frerker, Christian, Seiffert, Moritz, Sinning, Jan-Malte, Bekeredjian, Raffi, Walther, Thomas, Beyersdorf, Friedhelm, Möllmann, Helge, Balaban, Ümniye, Eghbalzadeh, Kaveh, Rudolph, Tanja K., Bleiziffer, Sabine
Format Journal Article
LanguageEnglish
Published Berlin/Heidelberg Springer Berlin Heidelberg 01.03.2025
Springer Nature B.V
Subjects
Online AccessGet full text
ISSN1861-0684
1861-0692
1861-0692
DOI10.1007/s00392-024-02402-9

Cover

Abstract Background In patients not suitable for transfemoral transcatheter aortic valve implantation (TAVI), several access strategies can be chosen. Aim To evaluate the use and patient outcomes of transaxillary (TAx), transapical (TA), and transaortic (TAo) as alternative access for TAVI in Germany; to further evaluate surgical cutdown vs. percutaneous TAx access. Methods All patients entered the German Aortic Valve Registry (GARY) between 2011 and 2019 who underwent non-transfemoral TAVI were included in this analysis. Patients with TA, TAo, or TAx TAVI were compared using a weighted propensity score model. Furthermore, a subgroup analysis was performed for TAx regarding the percutaneous or surgical cutdown approach. Results Overall, 9686 patients received a non-transfemoral access. A total of 8918 patients (92.1%) underwent TA, 398 (4.1%) TAo, and 370 (3.8%) TAx approaches. Within the TAx subgroup, 141 patients (38.1%) received subclavian cutdown, while 200 (54.1%) underwent a percutaneous approach. The TA patients had a significantly lower 30-day survival than TAx patients (TA 90.92% vs. TAx 95.59%, p  = 0.006; TAo 92.22% vs. TAx 95.59%, p  = 0.102). Comparing percutaneous and cutdown TAx approaches, no significant differences were seen. However, more vascular complications occurred (TA 1.8%, TAo 2.4%, TAx 12.2%; p  < .001), and the hospital length of stay was shorter (TA 12.9 days, TAo 14.1 days, TAx 12 days; p  < .001) after TAx access. Conclusion It may be reasonable to consider TAx access first in patients not suitable for TF-TAVI, because the 30-day survival was higher compared with TA access and the 1-year survival was higher compared with TAo access. It remains important for the heart teams to offer alternative access modalities for patients not amenable to the standard TF-TAVI approaches. Graphical Abstract
AbstractList BackgroundIn patients not suitable for transfemoral transcatheter aortic valve implantation (TAVI), several access strategies can be chosen.AimTo evaluate the use and patient outcomes of transaxillary (TAx), transapical (TA), and transaortic (TAo) as alternative access for TAVI in Germany; to further evaluate surgical cutdown vs. percutaneous TAx access.MethodsAll patients entered the German Aortic Valve Registry (GARY) between 2011 and 2019 who underwent non-transfemoral TAVI were included in this analysis. Patients with TA, TAo, or TAx TAVI were compared using a weighted propensity score model. Furthermore, a subgroup analysis was performed for TAx regarding the percutaneous or surgical cutdown approach.ResultsOverall, 9686 patients received a non-transfemoral access. A total of 8918 patients (92.1%) underwent TA, 398 (4.1%) TAo, and 370 (3.8%) TAx approaches. Within the TAx subgroup, 141 patients (38.1%) received subclavian cutdown, while 200 (54.1%) underwent a percutaneous approach. The TA patients had a significantly lower 30-day survival than TAx patients (TA 90.92% vs. TAx 95.59%, p = 0.006; TAo 92.22% vs. TAx 95.59%, p = 0.102). Comparing percutaneous and cutdown TAx approaches, no significant differences were seen. However, more vascular complications occurred (TA 1.8%, TAo 2.4%, TAx 12.2%; p < .001), and the hospital length of stay was shorter (TA 12.9 days, TAo 14.1 days, TAx 12 days; p < .001) after TAx access.ConclusionIt may be reasonable to consider TAx access first in patients not suitable for TF-TAVI, because the 30-day survival was higher compared with TA access and the 1-year survival was higher compared with TAo access. It remains important for the heart teams to offer alternative access modalities for patients not amenable to the standard TF-TAVI approaches.
Background In patients not suitable for transfemoral transcatheter aortic valve implantation (TAVI), several access strategies can be chosen. Aim To evaluate the use and patient outcomes of transaxillary (TAx), transapical (TA), and transaortic (TAo) as alternative access for TAVI in Germany; to further evaluate surgical cutdown vs. percutaneous TAx access. Methods All patients entered the German Aortic Valve Registry (GARY) between 2011 and 2019 who underwent non-transfemoral TAVI were included in this analysis. Patients with TA, TAo, or TAx TAVI were compared using a weighted propensity score model. Furthermore, a subgroup analysis was performed for TAx regarding the percutaneous or surgical cutdown approach. Results Overall, 9686 patients received a non-transfemoral access. A total of 8918 patients (92.1%) underwent TA, 398 (4.1%) TAo, and 370 (3.8%) TAx approaches. Within the TAx subgroup, 141 patients (38.1%) received subclavian cutdown, while 200 (54.1%) underwent a percutaneous approach. The TA patients had a significantly lower 30-day survival than TAx patients (TA 90.92% vs. TAx 95.59%, p  = 0.006; TAo 92.22% vs. TAx 95.59%, p  = 0.102). Comparing percutaneous and cutdown TAx approaches, no significant differences were seen. However, more vascular complications occurred (TA 1.8%, TAo 2.4%, TAx 12.2%; p  < .001), and the hospital length of stay was shorter (TA 12.9 days, TAo 14.1 days, TAx 12 days; p  < .001) after TAx access. Conclusion It may be reasonable to consider TAx access first in patients not suitable for TF-TAVI, because the 30-day survival was higher compared with TA access and the 1-year survival was higher compared with TAo access. It remains important for the heart teams to offer alternative access modalities for patients not amenable to the standard TF-TAVI approaches. Graphical Abstract
In patients not suitable for transfemoral transcatheter aortic valve implantation (TAVI), several access strategies can be chosen. To evaluate the use and patient outcomes of transaxillary (TAx), transapical (TA), and transaortic (TAo) as alternative access for TAVI in Germany; to further evaluate surgical cutdown vs. percutaneous TAx access. All patients entered the German Aortic Valve Registry (GARY) between 2011 and 2019 who underwent non-transfemoral TAVI were included in this analysis. Patients with TA, TAo, or TAx TAVI were compared using a weighted propensity score model. Furthermore, a subgroup analysis was performed for TAx regarding the percutaneous or surgical cutdown approach. Overall, 9686 patients received a non-transfemoral access. A total of 8918 patients (92.1%) underwent TA, 398 (4.1%) TAo, and 370 (3.8%) TAx approaches. Within the TAx subgroup, 141 patients (38.1%) received subclavian cutdown, while 200 (54.1%) underwent a percutaneous approach. The TA patients had a significantly lower 30-day survival than TAx patients (TA 90.92% vs. TAx 95.59%, p = 0.006; TAo 92.22% vs. TAx 95.59%, p = 0.102). Comparing percutaneous and cutdown TAx approaches, no significant differences were seen. However, more vascular complications occurred (TA 1.8%, TAo 2.4%, TAx 12.2%; p < .001), and the hospital length of stay was shorter (TA 12.9 days, TAo 14.1 days, TAx 12 days; p < .001) after TAx access. It may be reasonable to consider TAx access first in patients not suitable for TF-TAVI, because the 30-day survival was higher compared with TA access and the 1-year survival was higher compared with TAo access. It remains important for the heart teams to offer alternative access modalities for patients not amenable to the standard TF-TAVI approaches.
In patients not suitable for transfemoral transcatheter aortic valve implantation (TAVI), several access strategies can be chosen.BACKGROUNDIn patients not suitable for transfemoral transcatheter aortic valve implantation (TAVI), several access strategies can be chosen.To evaluate the use and patient outcomes of transaxillary (TAx), transapical (TA), and transaortic (TAo) as alternative access for TAVI in Germany; to further evaluate surgical cutdown vs. percutaneous TAx access.AIMTo evaluate the use and patient outcomes of transaxillary (TAx), transapical (TA), and transaortic (TAo) as alternative access for TAVI in Germany; to further evaluate surgical cutdown vs. percutaneous TAx access.All patients entered the German Aortic Valve Registry (GARY) between 2011 and 2019 who underwent non-transfemoral TAVI were included in this analysis. Patients with TA, TAo, or TAx TAVI were compared using a weighted propensity score model. Furthermore, a subgroup analysis was performed for TAx regarding the percutaneous or surgical cutdown approach.METHODSAll patients entered the German Aortic Valve Registry (GARY) between 2011 and 2019 who underwent non-transfemoral TAVI were included in this analysis. Patients with TA, TAo, or TAx TAVI were compared using a weighted propensity score model. Furthermore, a subgroup analysis was performed for TAx regarding the percutaneous or surgical cutdown approach.Overall, 9686 patients received a non-transfemoral access. A total of 8918 patients (92.1%) underwent TA, 398 (4.1%) TAo, and 370 (3.8%) TAx approaches. Within the TAx subgroup, 141 patients (38.1%) received subclavian cutdown, while 200 (54.1%) underwent a percutaneous approach. The TA patients had a significantly lower 30-day survival than TAx patients (TA 90.92% vs. TAx 95.59%, p = 0.006; TAo 92.22% vs. TAx 95.59%, p = 0.102). Comparing percutaneous and cutdown TAx approaches, no significant differences were seen. However, more vascular complications occurred (TA 1.8%, TAo 2.4%, TAx 12.2%; p < .001), and the hospital length of stay was shorter (TA 12.9 days, TAo 14.1 days, TAx 12 days; p < .001) after TAx access.RESULTSOverall, 9686 patients received a non-transfemoral access. A total of 8918 patients (92.1%) underwent TA, 398 (4.1%) TAo, and 370 (3.8%) TAx approaches. Within the TAx subgroup, 141 patients (38.1%) received subclavian cutdown, while 200 (54.1%) underwent a percutaneous approach. The TA patients had a significantly lower 30-day survival than TAx patients (TA 90.92% vs. TAx 95.59%, p = 0.006; TAo 92.22% vs. TAx 95.59%, p = 0.102). Comparing percutaneous and cutdown TAx approaches, no significant differences were seen. However, more vascular complications occurred (TA 1.8%, TAo 2.4%, TAx 12.2%; p < .001), and the hospital length of stay was shorter (TA 12.9 days, TAo 14.1 days, TAx 12 days; p < .001) after TAx access.It may be reasonable to consider TAx access first in patients not suitable for TF-TAVI, because the 30-day survival was higher compared with TA access and the 1-year survival was higher compared with TAo access. It remains important for the heart teams to offer alternative access modalities for patients not amenable to the standard TF-TAVI approaches.CONCLUSIONIt may be reasonable to consider TAx access first in patients not suitable for TF-TAVI, because the 30-day survival was higher compared with TA access and the 1-year survival was higher compared with TAo access. It remains important for the heart teams to offer alternative access modalities for patients not amenable to the standard TF-TAVI approaches.
Author Walther, Thomas
Bekeredjian, Raffi
Eghbalzadeh, Kaveh
Beyersdorf, Friedhelm
Rudolph, Tanja K.
Frerker, Christian
Seiffert, Moritz
Meertens, Max M.
Beckmann, Andreas
Adam, Matti
Balaban, Ümniye
Sinning, Jan-Malte
Bleiziffer, Sabine
Ensminger, Stephan
Möllmann, Helge
Author_xml – sequence: 1
  givenname: Max M.
  orcidid: 0000-0002-7746-8723
  surname: Meertens
  fullname: Meertens, Max M.
  email: max.meertens@me.com
  organization: Department III of Internal Medicine, University Hospital of Cologne
– sequence: 2
  givenname: Matti
  surname: Adam
  fullname: Adam, Matti
  organization: Department III of Internal Medicine, University Hospital of Cologne
– sequence: 3
  givenname: Andreas
  surname: Beckmann
  fullname: Beckmann, Andreas
  organization: Department of Cardiac and Pediatric Cardiac Surgery, Evanglish Clinical Center Niederrhein, Heart Center Duisburg
– sequence: 4
  givenname: Stephan
  surname: Ensminger
  fullname: Ensminger, Stephan
  organization: Department of Cardiac and Thoracic Vascular Surgery, University Heart Center Lübeck, University Hospital of Schleswig Holstein, German Center for Cardiovascular Research (DZHK), Partner Sie Hamburg-Kiel-Lübeck
– sequence: 5
  givenname: Christian
  surname: Frerker
  fullname: Frerker, Christian
  organization: German Center for Cardiovascular Research (DZHK), Partner Sie Hamburg-Kiel-Lübeck, Department of Cardiology, Angiology and Intensive Care Medicine, University Heart Center Lübeck, University Hospital Schleswig-Holstein
– sequence: 6
  givenname: Moritz
  surname: Seiffert
  fullname: Seiffert, Moritz
  organization: German Center for Cardiovascular Research (DZHK), Partner Sie Hamburg-Kiel-Lübeck, University Heart and Vascular Center Hamburg
– sequence: 7
  givenname: Jan-Malte
  surname: Sinning
  fullname: Sinning, Jan-Malte
  organization: Department of Cardiology, St Vinzenz Hospital
– sequence: 8
  givenname: Raffi
  surname: Bekeredjian
  fullname: Bekeredjian, Raffi
  organization: Department of Cardiology and Angiology, Robert-Bosch-Krankenhaus
– sequence: 9
  givenname: Thomas
  surname: Walther
  fullname: Walther, Thomas
  organization: Department of Cardiovascular Surgery, University Hospital Frankfurt and Goethe University Frankfurt
– sequence: 10
  givenname: Friedhelm
  surname: Beyersdorf
  fullname: Beyersdorf, Friedhelm
  organization: Department of Cardiovascular Surgery, Heart Centre Freiburg University
– sequence: 11
  givenname: Helge
  surname: Möllmann
  fullname: Möllmann, Helge
  organization: The Department of Internal Medicine, St.-Johannes-Hospital Dortmund
– sequence: 12
  givenname: Ümniye
  surname: Balaban
  fullname: Balaban, Ümniye
  organization: Institute of Biostatistics and Mathematical Modelling, Goethe-University
– sequence: 13
  givenname: Kaveh
  surname: Eghbalzadeh
  fullname: Eghbalzadeh, Kaveh
  organization: Department of Cardiothoracic Surgery, University Hospital Cologne
– sequence: 14
  givenname: Tanja K.
  surname: Rudolph
  fullname: Rudolph, Tanja K.
  organization: Department for General and Interventional Cardiology/Angiology, Heart and Diabetes Center North Rhine-Westphalia Bochum, University Hospital of the Ruhr University
– sequence: 15
  givenname: Sabine
  surname: Bleiziffer
  fullname: Bleiziffer, Sabine
  email: sbleiziffer@hdz-nrw.de
  organization: Department of Thoracic and Cardiovascular Surgery, Heart and Diabetes Center North Rhine-Westphalia, University Hospital Ruhr-University Bochum
BackLink https://www.ncbi.nlm.nih.gov/pubmed/38436739$$D View this record in MEDLINE/PubMed
BookMark eNp9UU1rFTEUDVKxH_oHXEjATTejNx-TSdzIo2gtFAWpBVchb3KnpsxLajIj9t-b8dWndtFFyA0559xz7zkkezFFJOQ5g1cMoHtdAIThDXC5HOCNeUQOmFasAWX43q7Wcp8clnIN0DIQ8gnZF1oK1QlzQC4_ptgMuEnZjXRI_VzQ0ym7WNzPMI4u31LX91gKDZFerC7P3tDT1eev1LvJURfdeFtCqYWnwzzNGSsXoy9PyePBjQWf3d1H5Mv7dxcnH5rzT6dnJ6vzppddOzVGcg6ATKFiyolubVB6PniHng1-bUD7VgMXppWDU6BRo1RyLYHVV2u4OCJvt7o383qDvsdYvY_2JodNtW6TC_b_nxi-2av0wzJmmDBiUTi-U8jp-4xlsptQeqyjR0xzsdyITgitjajQl_eg12nOdQfFCtZ1RrdC6Yp68a-lnZc_O68AvgX0OZWScdhBGNglWLsN1tZQ7e9g7ULS90h9mNwU0jJWGB-mii211D7xCvNf2w-wfgFf5rY2
CitedBy_id crossref_primary_10_3390_jcdd11070201
Cites_doi 10.1093/eurheartj/suaa050
10.1016/j.jcin.2019.01.219
10.1016/j.jcin.2022.12.009
10.1016/j.amjcard.2020.01.021
10.3389/fcvm.2022.798154
10.1093/eurheartj/ehab395
10.1093/eurheartj/ehy699
10.1016/j.athoracsur.2020.01.074
10.1016/j.athoracsur.2020.09.002
10.1093/ejcts/ezab216
10.1002/ccd.27416
10.1161/CIRCULATIONAHA.114.012525
10.1007/s11886-015-0694-5
10.1016/j.amjcard.2018.07.025
10.1055/s-0032-1323155
10.3390/jcm10071344
10.1016/j.jcin.2018.11.008
10.1002/ccd.27653
10.21037/jtd.2019.12.07
10.1007/s00392-022-01997-1
10.1080/24748706.2018.1497237
10.1016/j.jacc.2020.09.595
10.1136/bmj.i5130
10.1007/s11886-016-0788-8
10.1056/NEJMoa1814052
10.1016/j.jcin.2017.09.023
10.1016/j.jacc.2019.09.054
10.1136/bmjopen-2021-054222
ContentType Journal Article
Copyright The Author(s) 2024
2024. The Author(s).
Copyright Springer Nature B.V. Mar 2025
The Author(s) 2024 2024
Copyright_xml – notice: The Author(s) 2024
– notice: 2024. The Author(s).
– notice: Copyright Springer Nature B.V. Mar 2025
– notice: The Author(s) 2024 2024
DBID C6C
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
8FD
FR3
K9.
M7Z
P64
7X8
5PM
DOI 10.1007/s00392-024-02402-9
DatabaseName Springer Nature OA Free Journals
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Technology Research Database
Engineering Research Database
ProQuest Health & Medical Complete (Alumni)
Biochemistry Abstracts 1
Biotechnology and BioEngineering Abstracts
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Biochemistry Abstracts 1
ProQuest Health & Medical Complete (Alumni)
Engineering Research Database
Technology Research Database
Biotechnology and BioEngineering Abstracts
MEDLINE - Academic
DatabaseTitleList Biochemistry Abstracts 1

MEDLINE
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: C6C
  name: Springer Nature OA Free Journals
  url: http://www.springeropen.com/
  sourceTypes: Publisher
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1861-0692
EndPage 331
ExternalDocumentID PMC11913932
38436739
10_1007_s00392_024_02402_9
Genre Multicenter Study
Journal Article
GeographicLocations Germany
GeographicLocations_xml – name: Germany
GrantInformation_xml – fundername: Universitätsklinikum Köln (8977)
– fundername: Deutsches Zentrum fuer Herz-Kreislauf Forschung
GroupedDBID ---
-Y2
.VR
06C
06D
0R~
0VY
1N0
203
29B
29~
2J2
2JN
2JY
2KG
2LR
2P1
2VQ
2~H
30V
4.4
406
408
409
40D
40E
53G
5GY
5VS
67Z
6NX
7X7
88E
8AO
8FI
8FJ
8TC
8UJ
95-
95.
95~
96X
AAAVM
AABHQ
AACDK
AAHNG
AAIAL
AAJBT
AAJKR
AANXM
AANZL
AAPKM
AARHV
AARTL
AASML
AATNV
AATVU
AAUYE
AAWCG
AAYIU
AAYQN
AAYTO
AAYZH
ABAKF
ABBBX
ABBXA
ABDBE
ABDZT
ABECU
ABFTV
ABHLI
ABHQN
ABIPD
ABJNI
ABJOX
ABKCH
ABKTR
ABMNI
ABMQK
ABNWP
ABPLI
ABQBU
ABQSL
ABSXP
ABTEG
ABTKH
ABTMW
ABULA
ABUWG
ABWNU
ABXPI
ACAOD
ACBXY
ACDTI
ACGFS
ACHSB
ACHXU
ACIWK
ACKNC
ACMDZ
ACMLO
ACOKC
ACOMO
ACPIV
ACPRK
ACSNA
ACZOJ
ADBBV
ADHIR
ADHKG
ADKNI
ADKPE
ADRFC
ADTPH
ADURQ
ADYFF
ADZKW
AEBTG
AEFQL
AEGAL
AEGNC
AEJHL
AEJRE
AEKMD
AEMSY
AENEX
AEOHA
AEPYU
AESKC
AETLH
AEVLU
AEXYK
AFBBN
AFKRA
AFLOW
AFQWF
AFRAH
AFWTZ
AFZKB
AGAYW
AGDGC
AGJBK
AGMZJ
AGQEE
AGQMX
AGRTI
AGWIL
AGWZB
AGYKE
AHAVH
AHBYD
AHIZS
AHKAY
AHMBA
AHSBF
AHYZX
AIAKS
AIGIU
AIIXL
AILAN
AITGF
AJBLW
AJRNO
AJZVZ
AKMHD
ALIPV
ALMA_UNASSIGNED_HOLDINGS
ALWAN
AMKLP
AMXSW
AMYLF
AOCGG
ARMRJ
ASPBG
AVWKF
AXYYD
AYFIA
AZFZN
B-.
BA0
BDATZ
BENPR
BGNMA
BPHCQ
BSONS
BVXVI
C6C
CAG
CCPQU
COF
CS3
CSCUP
DDRTE
DNIVK
DPUIP
DU5
EBD
EBLON
EBS
EIOEI
EJD
EMOBN
EN4
ESBYG
F5P
FEDTE
FERAY
FFXSO
FIGPU
FINBP
FNLPD
FRRFC
FSGXE
FWDCC
FYUFA
G-Y
G-Z
GGCAI
GGRSB
GJIRD
GNWQR
GQ7
GQ8
GXS
H13
HF~
HG5
HG6
HMCUK
HMJXF
HQYDN
HRMNR
HVGLF
HZ~
IJ-
IKXTQ
IMOTQ
IWAJR
IXC
IXD
IXE
IZIGR
IZQ
I~X
I~Z
J-C
J0Z
JBSCW
JCJTX
JZLTJ
KDC
KOV
KPH
LLZTM
M1P
M4Y
MA-
N2Q
N9A
NB0
NPVJJ
NQJWS
NU0
O9-
O93
O9I
O9J
OAM
P9S
PF0
PHGZT
PQQKQ
PROAC
PSQYO
PT4
Q2X
QOR
QOS
R89
R9I
ROL
RSV
S16
S1Z
S27
S37
S3B
SAP
SDH
SHX
SISQX
SJYHP
SMD
SNE
SNPRN
SNX
SOHCF
SOJ
SPISZ
SRMVM
SSLCW
SSXJD
STPWE
SV3
SZ9
SZN
T13
TSG
TSK
TSV
TT1
TUC
U9L
UG4
UKHRP
UOJIU
UTJUX
UZXMN
VC2
VFIZW
W23
W48
WJK
WK8
YLTOR
Z45
ZMTXR
ZOVNA
~KM
AAYXX
ABBRH
ABFSG
ABRTQ
ACSTC
AEZWR
AFDZB
AFHIU
AFOHR
AGQPQ
AHPBZ
AHWEU
AIXLP
ATHPR
CITATION
PHGZM
PJZUB
PPXIY
CGR
CUY
CVF
ECM
EIF
NPM
8FD
FR3
K9.
M7Z
P64
7X8
5PM
ID FETCH-LOGICAL-c475t-942200e16e616a37b9e4d2fdaed1fdb908d58023954fa608e8e464b401a605923
IEDL.DBID C6C
ISSN 1861-0684
1861-0692
IngestDate Thu Aug 21 18:40:16 EDT 2025
Fri Sep 05 00:13:27 EDT 2025
Fri Jul 25 21:12:01 EDT 2025
Sun May 11 01:41:26 EDT 2025
Tue Aug 05 12:02:13 EDT 2025
Thu Apr 24 23:08:23 EDT 2025
Tue Mar 18 01:10:42 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 3
Keywords Transapical
Transaortic
GARY
Transaxillary
Transsubclavian
TAVI
Transfemoral
Language English
License 2024. The Author(s).
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c475t-942200e16e616a37b9e4d2fdaed1fdb908d58023954fa608e8e464b401a605923
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0002-7746-8723
OpenAccessLink https://doi.org/10.1007/s00392-024-02402-9
PMID 38436739
PQID 3177985368
PQPubID 326353
PageCount 9
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_11913932
proquest_miscellaneous_2937338893
proquest_journals_3177985368
pubmed_primary_38436739
crossref_primary_10_1007_s00392_024_02402_9
crossref_citationtrail_10_1007_s00392_024_02402_9
springer_journals_10_1007_s00392_024_02402_9
PublicationCentury 2000
PublicationDate 2025-03-01
PublicationDateYYYYMMDD 2025-03-01
PublicationDate_xml – month: 03
  year: 2025
  text: 2025-03-01
  day: 01
PublicationDecade 2020
PublicationPlace Berlin/Heidelberg
PublicationPlace_xml – name: Berlin/Heidelberg
– name: Germany
– name: Heidelberg
PublicationTitle Clinical research in cardiology
PublicationTitleAbbrev Clin Res Cardiol
PublicationTitleAlternate Clin Res Cardiol
PublicationYear 2025
Publisher Springer Berlin Heidelberg
Springer Nature B.V
Publisher_xml – name: Springer Berlin Heidelberg
– name: Springer Nature B.V
References Y Zhan (2402_CR9) 2019; 11
MM Meertens (2402_CR23) 2022; 111
SL Swift (2402_CR18) 2021; 11
D Eckner (2402_CR26) 2021; 10
JD Carroll (2402_CR14) 2020; 76
JS Patel (2402_CR7) 2016; 18
A Habertheuer (2402_CR29) 2020; 110
CJ Chung (2402_CR22) 2022; 17
N Buzzatti (2402_CR15) 2020; 22
D Caruso (2402_CR6) 2016; 18
L Stastny (2402_CR11) 2022; 9
N Kumar (2402_CR3) 2018; 122
AA Khan (2402_CR4) 2018; 2
F Beyersdorf (2402_CR20) 2021; 60
HK Abdelaziz (2402_CR25) 2020; 125
S Beurtheret (2402_CR1) 2019; 74
DM Arnett (2402_CR8) 2018; 91
MJ Mack (2402_CR2) 2019; 380
JD Carroll (2402_CR13) 2021; 111
TG Dahle (2402_CR24) 2019; 12
SV Arnold (2402_CR28) 2019; 12
RA Siemieniuk (2402_CR19) 2016; 354
A Beckmann (2402_CR10) 2012; 60
P Tullio (2402_CR12) 2023; 16
A Vahanian (2402_CR5) 2021; 43
R Bekeredjian (2402_CR21) 2019; 40
S Elmariah (2402_CR17) 2017; 10
I Ates (2402_CR27) 2018; 91
EH Blackstone (2402_CR16) 2015; 131
References_xml – volume: 22
  start-page: E7
  issue: Supplement_E
  year: 2020
  ident: 2402_CR15
  publication-title: Eur Hear J Suppl
  doi: 10.1093/eurheartj/suaa050
– volume: 12
  start-page: 662
  issue: 7
  year: 2019
  ident: 2402_CR24
  publication-title: JACC Cardiovasc Interv
  doi: 10.1016/j.jcin.2019.01.219
– volume: 16
  start-page: 396
  issue: 4
  year: 2023
  ident: 2402_CR12
  publication-title: JACC Cardiovasc Interv
  doi: 10.1016/j.jcin.2022.12.009
– volume: 125
  start-page: 1239
  issue: 8
  year: 2020
  ident: 2402_CR25
  publication-title: Am J Cardiol
  doi: 10.1016/j.amjcard.2020.01.021
– volume: 9
  start-page: 798154
  year: 2022
  ident: 2402_CR11
  publication-title: Front Cardiovasc Med
  doi: 10.3389/fcvm.2022.798154
– volume: 43
  start-page: 561
  issue: 7
  year: 2021
  ident: 2402_CR5
  publication-title: Eur Heart J
  doi: 10.1093/eurheartj/ehab395
– volume: 40
  start-page: 1323
  issue: 17
  year: 2019
  ident: 2402_CR21
  publication-title: Eur Heart J
  doi: 10.1093/eurheartj/ehy699
– volume: 110
  start-page: 1294
  issue: 4
  year: 2020
  ident: 2402_CR29
  publication-title: Ann Thorac Surg
  doi: 10.1016/j.athoracsur.2020.01.074
– volume: 17
  start-page: 1514
  issue: 18
  year: 2022
  ident: 2402_CR22
  publication-title: EuroIntervention J Eur Collab with Work Gr Interv Cardiol Eur Soc Cardiol
– volume: 111
  start-page: 701
  issue: 2
  year: 2021
  ident: 2402_CR13
  publication-title: Ann Thorac Surg
  doi: 10.1016/j.athoracsur.2020.09.002
– volume: 60
  start-page: 1139
  issue: 5
  year: 2021
  ident: 2402_CR20
  publication-title: Eur J Cardio-Thoracic Surg
  doi: 10.1093/ejcts/ezab216
– volume: 91
  start-page: 150
  issue: 1
  year: 2018
  ident: 2402_CR8
  publication-title: Catheter Cardiovasc Interv Off J Soc Card Angiogr Interv
  doi: 10.1002/ccd.27416
– volume: 131
  start-page: 1989
  issue: 22
  year: 2015
  ident: 2402_CR16
  publication-title: Circulation
  doi: 10.1161/CIRCULATIONAHA.114.012525
– volume: 18
  start-page: 14
  issue: 2
  year: 2016
  ident: 2402_CR6
  publication-title: Curr Cardiol Rep
  doi: 10.1007/s11886-015-0694-5
– volume: 122
  start-page: 1520
  issue: 9
  year: 2018
  ident: 2402_CR3
  publication-title: Am J Cardiol
  doi: 10.1016/j.amjcard.2018.07.025
– volume: 60
  start-page: 319
  issue: 5
  year: 2012
  ident: 2402_CR10
  publication-title: Thorac Cardiovasc Surg
  doi: 10.1055/s-0032-1323155
– volume: 10
  start-page: 1344
  issue: 7
  year: 2021
  ident: 2402_CR26
  publication-title: J Clin Med
  doi: 10.3390/jcm10071344
– volume: 12
  start-page: 362
  issue: 4
  year: 2019
  ident: 2402_CR28
  publication-title: JACC Cardiovasc Interv
  doi: 10.1016/j.jcin.2018.11.008
– volume: 91
  start-page: 1363
  issue: 7
  year: 2018
  ident: 2402_CR27
  publication-title: Catheter Cardiovasc Interv Off J Soc Card Angiogr & Interv
  doi: 10.1002/ccd.27653
– volume: 11
  start-page: 5140
  issue: 12
  year: 2019
  ident: 2402_CR9
  publication-title: J Thorac Dis
  doi: 10.21037/jtd.2019.12.07
– volume: 111
  start-page: 843
  issue: 8
  year: 2022
  ident: 2402_CR23
  publication-title: Clin Res Cardiol
  doi: 10.1007/s00392-022-01997-1
– volume: 2
  start-page: 463
  issue: 5
  year: 2018
  ident: 2402_CR4
  publication-title: Struct Hear
  doi: 10.1080/24748706.2018.1497237
– volume: 76
  start-page: 2492
  issue: 21
  year: 2020
  ident: 2402_CR14
  publication-title: J Am Coll Cardiol
  doi: 10.1016/j.jacc.2020.09.595
– volume: 354
  start-page: i5130
  year: 2016
  ident: 2402_CR19
  publication-title: BMJ
  doi: 10.1136/bmj.i5130
– volume: 18
  start-page: 110
  issue: 11
  year: 2016
  ident: 2402_CR7
  publication-title: Curr Cardiol Rep
  doi: 10.1007/s11886-016-0788-8
– volume: 380
  start-page: 1695
  issue: 18
  year: 2019
  ident: 2402_CR2
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa1814052
– volume: 10
  start-page: 2414
  issue: 23
  year: 2017
  ident: 2402_CR17
  publication-title: JACC Cardiovasc Interv
  doi: 10.1016/j.jcin.2017.09.023
– volume: 74
  start-page: 2728
  issue: 22
  year: 2019
  ident: 2402_CR1
  publication-title: J Am Coll Cardiol
  doi: 10.1016/j.jacc.2019.09.054
– volume: 11
  start-page: e054222
  issue: 12
  year: 2021
  ident: 2402_CR18
  publication-title: BMJ Open
  doi: 10.1136/bmjopen-2021-054222
SSID ssj0051034
Score 2.4111052
Snippet Background In patients not suitable for transfemoral transcatheter aortic valve implantation (TAVI), several access strategies can be chosen. Aim To evaluate...
In patients not suitable for transfemoral transcatheter aortic valve implantation (TAVI), several access strategies can be chosen. To evaluate the use and...
BackgroundIn patients not suitable for transfemoral transcatheter aortic valve implantation (TAVI), several access strategies can be chosen.AimTo evaluate the...
In patients not suitable for transfemoral transcatheter aortic valve implantation (TAVI), several access strategies can be chosen.BACKGROUNDIn patients not...
SourceID pubmedcentral
proquest
pubmed
crossref
springer
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 323
SubjectTerms Aged
Aged, 80 and over
Aorta
Aortic valve
Aortic Valve - surgery
Aortic Valve Stenosis - mortality
Aortic Valve Stenosis - surgery
Axillary Artery
Body mass index
Cardiology
Cardiovascular disease
Data analysis
Female
Femoral Artery
Germany - epidemiology
Heart valves
Humans
Length of stay
Male
Medicine
Medicine & Public Health
Mortality
Original Paper
Patients
Propensity Score
Registries
Retrospective Studies
Subgroups
Survival
Survival Rate - trends
Transcatheter Aortic Valve Replacement - methods
Transcatheter Aortic Valve Replacement - trends
Treatment Outcome
Trends
Title Non-femoral focused transaxillary access in TAVI: GARY data analysis and future trends
URI https://link.springer.com/article/10.1007/s00392-024-02402-9
https://www.ncbi.nlm.nih.gov/pubmed/38436739
https://www.proquest.com/docview/3177985368
https://www.proquest.com/docview/2937338893
https://pubmed.ncbi.nlm.nih.gov/PMC11913932
Volume 114
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3dS8MwED_Ugfgifls_RgTftLC2adr6NodzKtuDTHFPJV1SHEgr-wD9773Luso2FXwobeklbZNc8jvu8juAc7QYFNpcnl0L0DbhjpvaMgmULQWXNd13uVC0ObndEa0nfv_ivxQ0ObQXZsF_T2SfHsVHupwO1N5oFSo-Trw0mhuiMZt1iRjOeJBDQZE8IS82yPxcx_witIQslwMkF7ykZvFpbsFmgRpZfdrN27Cisx1Ybxd-8V147uSZnVLQLEqleX8y0oqNTSrwD0orNPxk0mRGZIOMdevPd1fstv7YYxQfymTBS4IXik05RrAshcruwVPzptto2UXGBLvPA39sR9zFUa8doYUjpBckkebKTZXUyklVEtVC5RPjW-TzVIpaqEPNBU_QxsI7H7HePqxleaYPgaWBkp4BFEJxw5KWiATRHpXwsXoLnFkTxv2CTpyyWrzFJRGyafYYmzw2zR5HFlyUZd6nZBp_Sp_MeiYuFGsUI9wJIoQYIrTgrHyMKkF-DpnpfDKKEcEEaHkjErPgYNqR5eu8kHsi8LDycK6LSwGi255_kg1eDe02UeF5CHctuJyNhu_v-v03jv4nfgwbLqUYNmFuJ7A2Hk70KeKecVKFSr15fd2h823v4aZqFOALxYv4Xg
linkProvider Springer Nature
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3dS8MwED_8APVF_LZ-RvBNC2ubpq1vY6jzY3uQbehTSJcUBenEbaD_vXdZV9mmgg-Fll7S9i5pfsddfgdwih6DRp8rcCsR-ibc8zNXpZF2leCqYro-F5o2Jzeaot7mt4_hY0GTQ3thpuL3RPYZUH6kz-nA2ZvMwyJFLoknvyZq478uEcPZCHIsKJMn5sUGmZ_7mFyEZpDlbILkVJTULj5Xa7BaoEZWHZl5HeZMvgFLjSIuvgmdZi93M0qaRams1x32jWYDWwr8g8oKvX8yZSsjspectaqdmwt2XX14YpQfylTBS4Inmo04RrAtpcpuQfvqslWru0XFBLfLo3DgJtzHUW88YYQnVBClieHaz7Qy2st0mlRiHRLjWxLyTIlKbGLDBU_Rx8KrELHeNizkvdzsAssirQILKITmliUtFSmiPWoRYvcOeGMVym5BJ05VLV5lSYRs1S5R5dKqXSYOnJVt3kZkGn9KH4wtI4uJ1ZcId6IEIYaIHTgpb-OUoDiHyk1v2JeIYCL0vBGJObAzMmT5uCDmgYgC7DyeMHEpQHTbk3fyl2dLu01UeAHCXQfOx6Ph-71-_4y9_4kfw3K91biX9zfNu31Y8ancsE15O4CFwfvQHCIGGqRHdvB_AQby-D0
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3rS9xAEB_aE6Rf1NpW46Ndod_a6CXZbBK_Her5PkpR0U_LJrtBUXLi5UD9653ZPOppWyj9EEjYR7KPyf6GmfkNwFfUGDTqXIHbjVA34Z6fuyqNtKsEV12T-VxoCk4-Hoi9U35wHp4_i-K33u6NSbKKaSCWpqLcuNX5Rhv4RiGlvovnC10o08lbmOKUQ6IDU73di8Od5m9MhHHWshwL8vCJeR048_teJg-nV4jztePkC-upPZT6s6Ca4VS-KNfr4zJdzx5fMD3-z3jnYKZGrKxXbbH38MYU8zB9XNvkP8DZYFi4OTnsYq18mI1HRrPSpiG_p5RGdw9M2ayM7KpgJ72z_U222_t5wcg3lamaEwVvNKv4TbAtuel-hNP-zsnWnltna3AzHoWlm3AfJc54wghPqCBKE8O1n2tltJfrNOnGOiS2uSTkuRLd2MSGC56ifodPIeLMT9AphoVZBJZHWgUWzAjNLUNbKlJEmtQixO4d8JplkllNZU4ZNW5kS8JsJ0ziZEk7YTJx4Fvb5rYi8vhr7ZVm9WUt1COJUCtKEN6I2IG1thjFkWwsqjDD8UgieopQ60cU6MBCtVna1wUxD0QUYOfxxDZqKxDV92RJcXVpKb-Jhi9AqO3A92az_PquPw9j6d-qf4HpH9t9ebQ_OFyGdz5lOrbedivQKe_GZhXhV5l-riXsCUocIj4
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Non-femoral+focused+transaxillary+access+in+TAVI%3A+GARY+data+analysis+and+future+trends&rft.jtitle=Clinical+research+in+cardiology&rft.au=Meertens%2C+Max+M.&rft.au=Adam%2C+Matti&rft.au=Beckmann%2C+Andreas&rft.au=Ensminger%2C+Stephan&rft.date=2025-03-01&rft.issn=1861-0684&rft.eissn=1861-0692&rft.volume=114&rft.issue=3&rft.spage=323&rft.epage=331&rft_id=info:doi/10.1007%2Fs00392-024-02402-9&rft.externalDBID=n%2Fa&rft.externalDocID=10_1007_s00392_024_02402_9
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1861-0684&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1861-0684&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1861-0684&client=summon